Literature DB >> 7944538

Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review.

N Banatvala1, J Davies, M Kanariou, S Strobel, R Levinsky, G Morgan.   

Abstract

The clinical and immunological aspects of 16 children with the syndrome of hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome) and their responses to treatment are reviewed. Increased concentrations of IgM, neutropenia, and recurrent infections could usually be controlled by antimicrobial and intravenous immunoglobulin treatment. Together with the bacterial infections characteristic of hypogammaglobulinaemia, these patients often developed opportunistic infections, including Pneumocystis carinii pneumonia, often presenting in the first year of life. The occurrence of sclerosing cholangitis, neurological complications, and neutropenia may be a result of an underlying cell mediated immune deficiency, autoimmunity, or infection. Despite a high incidence of opportunistic infections, immunological investigations did not show any abnormality of T cell function. These findings are discussed in the light of the recent demonstration that the lack of expression of a T lymphocyte activation antigen is the molecular basis of the X linked form of the disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944538      PMCID: PMC1029949          DOI: 10.1136/adc.71.2.150

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  PNEUMOCYSTIS CARINII PNEUMONIA AND CONGENITAL HYPOGAMMAGLOBULINAEMIA.

Authors:  W C MARSHALL; H J WESTON; M BODIAN
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

2.  Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M.

Authors:  L Mayer; S P Kwan; C Thompson; H S Ko; N Chiorazzi; T Waldmann; F Rosen
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

3.  Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency.

Authors:  Y L Lau; R J Levinsky; G Morgan; S Strobel
Journal:  Pediatr Infect Dis J       Date:  1988-12       Impact factor: 2.129

4.  Immunologic studies of three family members with the immunodeficiency with hyper-IgM syndrome.

Authors:  Z Brahmi; K H Lazarus; M E Hodes; R L Baehner
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

Review 5.  Immunodeficiency with hyper-IgM (HIM).

Authors:  L D Notarangelo; M Duse; A G Ugazio
Journal:  Immunodefic Rev       Date:  1992

Review 6.  Infectious complications of the primary immunodeficiencies.

Authors:  E R Stiehm; T W Chin; A Haas; A G Peerless
Journal:  Clin Immunol Immunopathol       Date:  1986-07

7.  Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT.

Authors:  M Padayachee; C Feighery; A Finn; C McKeown; R J Levinsky; C Kinnon; S Malcolm
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

8.  Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact.

Authors:  R W Hendriks; M E Kraakman; I W Craig; T Espanol; R K Schuurman
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

9.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

10.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

  10 in total
  11 in total

1.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

Review 4.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

5.  Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients.

Authors:  Otavio Cabral-Marques; Lena-Friederike Schimke; Paulo Vítor Soeiro Pereira; Angela Falcai; João Bosco de Oliveira; Mary J Hackett; Paolo Ruggero Errante; Cristina Worm Weber; Janaíra Fernandes Ferreira; Gisele Kuntze; Nelson Augusto Rosário-Filho; Hans D Ochs; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2011-12-23       Impact factor: 8.317

6.  CD40 ligand deficiency presenting as unresponsive neutropenia.

Authors:  F J Andrews; F Katz; A Jones; S Smith; A Finn
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

Review 7.  Immunogenetics: changing the face of immunodeficiency.

Authors:  A M Jones; H B Gaspar
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

8.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

Review 9.  X-linked immunodeficiency with hyper-IgM (XHIM).

Authors:  L D Notarangelo; A R Hayward
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 10.  X-linked hyper IgM syndrome.

Authors:  L C Schneider
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.